Study On Histoacryl Used For Embolization Of Middle Meningeal Artery (MMA) In Chronic Subdural Hematoma (CSDH) (HARMONY)

NCT07258069 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2026-04-17

No results posted yet for this study

Summary

The aim of the study is to proof the effectiveness of Histoacryl® on preventing recurrence or progression of subdural hematoma after embolization of the middle meningeal artery.

Conditions

  • Subdural Hematoma
  • Subdural Hematoma, Chronic

Interventions

DEVICE

Histoacryl®

Histoacryl® is used by direct needle puncture, transcatheter approach, or transendoscopic approach in vascular embolization for the described purposes.

Sponsors & Collaborators

  • Aesculap AG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-10
Primary Completion
2026-12-31
Completion
2027-08-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07258069 on ClinicalTrials.gov